Mortality outcomes associated with oral corticosteroid use in patients with COPD

Gary  Tse; David Price; Mona Bafadhel; Alberto Papi; Victoria Carter; Cono  Ariti; Jiandong  Zhou; Derek Skinner; Xiao Xu; Hana  Müllerová; Benjamin  Emmanuel

doi:10.1183/13993003.congress-2022.1819

Mortality outcomes associated with oral corticosteroid use in patients with COPD

Gary Tse
, David Price
, Mona Bafadhel
, Alberto Papi
, Victoria Carter
, Cono Ariti
, Jiandong Zhou
, Derek Skinner
, Xiao Xu
, Hana Müllerová
, Benjamin Emmanuel

Optimum Patient Care Ltd, Cambridge
Observational and Pragmatic Research Institute Singapore
AstraZeneca
AstraZeneca, Gaithersburg

Research output: Contribution to journal › Abstract › peer-review

3 Downloads (Pure)

Original language	English
Article number	1819
Number of pages	1
Journal	European Respiratory Journal
Volume	60
Issue number	66
Early online date	30 Nov 2022
DOIs	https://doi.org/10.1183/13993003.congress-2022.1819
Publication status	Published - 1 Dec 2022
Event	European Respiratory Society (ERS) International Congress. - FIRA Barcelona Gran Via Congress Centre, Barcelona, Spain Duration: 4 Sept 2022 → 6 Sept 2022 https://www.ersnet.org/congress-and-events/congress/

Bibliographical note

Research funding source: This study was supported by AstraZeneca.

Keywords

COPD
COPD – management
Treatments

Access to Document

10.1183/13993003.congress-2022.1819Licence: Unspecified

Tse_etal_ERS2022_Mortality_Outcomes_Associated_AAMAccepted author manuscript, 216 KBLicence: Unspecified

Cite this

@article{b7e84c58b59e4b5ba8894fcf04b9d063,

title = "Mortality outcomes associated with oral corticosteroid use in patients with COPD",

keywords = "COPD, COPD {\textendash} management, Treatments",

author = "Gary Tse and David Price and Mona Bafadhel and Alberto Papi and Victoria Carter and Cono Ariti and Jiandong Zhou and Derek Skinner and Xiao Xu and Hana M{\"u}llerov{\'a} and Benjamin Emmanuel",

note = "Research funding source: This study was supported by AstraZeneca.; European Respiratory Society (ERS) International Congress., ERS International Congress 2022 ; Conference date: 04-09-2022 Through 06-09-2022",

year = "2022",

month = dec,

day = "1",

doi = "10.1183/13993003.congress-2022.1819",

language = "English",

volume = "60",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "66",

url = "https://www.ersnet.org/congress-and-events/congress/",

}

TY - JOUR

T1 - Mortality outcomes associated with oral corticosteroid use in patients with COPD

AU - Tse, Gary

AU - Price, David

AU - Bafadhel, Mona

AU - Papi, Alberto

AU - Carter, Victoria

AU - Ariti, Cono

AU - Zhou, Jiandong

AU - Skinner, Derek

AU - Xu, Xiao

AU - Müllerová, Hana

AU - Emmanuel, Benjamin

N1 - Research funding source: This study was supported by AstraZeneca.

PY - 2022/12/1

Y1 - 2022/12/1

KW - COPD

KW - COPD – management

KW - Treatments

U2 - 10.1183/13993003.congress-2022.1819

DO - 10.1183/13993003.congress-2022.1819

M3 - Abstract

SN - 0903-1936

VL - 60

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 66

M1 - 1819

T2 - European Respiratory Society (ERS) International Congress.

Y2 - 4 September 2022 through 6 September 2022

ER -